Chopas James George
SEC insider (Form 3/4/5 filer). CIK 0001836430. VP/Chief Accounting Officer at Apellis Pharmaceuticals, Inc. (APLS). 29 reported Form 4/5 transactions since Sep 2024; latest on May 14, 2026. Located in WALTHAM, MA.
Companies Chopas James George has filed insider reports for
- Apellis Pharmaceuticals, Inc. (APLS): Officer, VP/Chief Accounting Officer
Chopas James George
CIK: 0001836430
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Apellis Pharmaceuticals, Inc.
Discretionary Trading P&L
Holdings
Transaction History (29 total)
- May 14, 2026APLS
Apellis Pharmaceuticals, Inc.
DispositionDirect8.1K shares- - May 14, 2026APLS
Apellis Pharmaceuticals, Inc.
Tender OfferDirect66K shares- - May 14, 2026APLS
Apellis Pharmaceuticals, Inc.
AwardDirect5.6K shares- - May 14, 2026APLS
Apellis Pharmaceuticals, Inc.
DispositionDirect5.6K shares- - May 14, 2026APLS
Apellis Pharmaceuticals, Inc.
AwardDirect8.4K shares- - May 14, 2026APLS
Apellis Pharmaceuticals, Inc.
DispositionDirect8.4K shares- - May 14, 2026APLS
Apellis Pharmaceuticals, Inc.
AwardDirect16.2K shares- - May 14, 2026APLS
Apellis Pharmaceuticals, Inc.
DispositionDirect16.2K shares- - May 14, 2026APLS
Apellis Pharmaceuticals, Inc.
AwardDirect8.1K shares- - May 14, 2026APLS
Apellis Pharmaceuticals, Inc.
DispositionDirect2.4K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| May 14, 2026 | APLS Apellis Pharmaceuticals, Inc. | Disposition | 8,075 | - | $0 | Direct |
| May 14, 2026 | APLS Apellis Pharmaceuticals, Inc. | Tender Offer | 65,955 | - | $0 | Direct |
| May 14, 2026 | APLS Apellis Pharmaceuticals, Inc. | Award | 5,625 | - | $0 | Direct |
| May 14, 2026 | APLS Apellis Pharmaceuticals, Inc. | Disposition | 5,625 | - | $0 | Direct |
| May 14, 2026 | APLS Apellis Pharmaceuticals, Inc. | Award | 8,394 | - | $0 | Direct |
| May 14, 2026 | APLS Apellis Pharmaceuticals, Inc. | Disposition | 8,394 | - | $0 | Direct |
| May 14, 2026 | APLS Apellis Pharmaceuticals, Inc. | Award | 16,150 | - | $0 | Direct |
| May 14, 2026 | APLS Apellis Pharmaceuticals, Inc. | Disposition | 16,150 | - | $0 | Direct |
| May 14, 2026 | APLS Apellis Pharmaceuticals, Inc. | Award | 8,075 | - | $0 | Direct |
| May 14, 2026 | APLS Apellis Pharmaceuticals, Inc. | Disposition | 2,406 | - | $0 | Direct |
1-10 of 29 transactions